ASSETS HELD-FOR-SALE AND DISCONTINUED OPERATIONS (Tables)

9 Months Ended

Nov. 03, 2018

Assets Held-for-sale And Discontinued Operations

Schedule of major classes of assets and liabilities

The following table provides a reconciliation of the carrying amounts of major classes of assets and liabilities which are included in assets and liabilities held-for-sale in the accompanying consolidated balance sheet for each of the periods presented:

	Entrust Discontinued Operations				Retail Pharmacy Discontinued Operations				Total Discontinued Operations
	November 3,		February 3,		November 3,		February 3,		November 3,		February 3,
	2018		2018		2018		2018		2018		2018
(in thousands)	(unaudited)				(unaudited)				(unaudited)
Current assets:
Receivables, less allowance for doubtful accounts	$	—	$	15,983	$	—	$	—	$	—	$	15,983
Inventories		—		3,756		13,849		15,344		13,849		19,100
Other non-trade receivables		—		152		—		—		—		152
Prepaid expenses and other current assets		—		12		—		—		—		12
Total current assets held-for-sale	$	—	$	19,903	$	13,849	$	15,344	$	13,849	$	35,247
Property and equipment, less accumulated depreciation and amortization		—		1,036		—		—		—		1,036
Goodwill		—		30,609		—		—		—		30,609
Intangible assets, net		—		9,533		16,471		20,541		16,471		30,074
Other noncurrent assets, net		—		539		—		—		—		539
Total noncurrent assets held-for-sale	$	—	$	41,717	$	16,471	$	20,541	$	16,471	$	62,258
Current liabilities:
Accounts payable		—		22,045		—		—		—		22,045
Accrued expenses and other		—		4,527		—		—		—		4,527
Total current liabilities held-for-sale	$	—	$	26,572	$	—	$	—	$	—	$	26,572
Deferred income taxes		—		—		—		—		—		—
Other noncurrent liabilities		—		48		—		—		—		48
Total noncurrent liabilities held-for-sale	$	—	$	48	$	—	$	—	$	—	$	48

Schedule of discontinued operations

The following tables summarize the results of discontinued operations for the thirteen and thirty nine weeks ended November 3, 2018, and October 28, 2017, respectively:

Discontinued Operations - Entrust 

	For the Thirteen Weeks Ended					For the Thirty Nine Weeks Ended
	(unaudited)					(unaudited)
	November 3,		October 28,			November 3,			October 28,
(in thousands)	2018		2017			2018			2017
Net Sales	$	—	$	68,168		$	90,112		$	205,626
Cost of goods sold		—		66,238			88,454			196,097
Gross profit		—		1,930			1,658			9,529
Depreciation and amortization		—		631			796			2,010
Selling, general and administrative expenses		—		2,763			12,398			8,424
Loss from discontinued operations		—		(1,464	)		(11,536	)		(905	)
Income tax expense		—		394			—			244
Loss from discontinued operations, net of tax	$	—	$	(1,858	)	$	(11,536	)	$	(1,149	)

Discontinued Operations - Retail Pharmacy

	For the Thirteen Weeks Ended					For the Thirty Nine Weeks Ended
	(unaudited)					(unaudited)
	November 3,		October 28,			November 3,			October 28,
(in thousands)	2018		2017			2018			2017
Net Sales	$	100,403	$	101,088		$	298,933		$	303,136
Cost of goods sold		80,948		78,432			241,695			230,847
Gross profit		19,455		22,656			57,238			72,289
Depreciation and amortization		616		1,751			4,071			5,549
Selling, general and administrative expenses		15,401		20,971			53,376			61,962
Income (loss) from discontinued operations		3,438		(66	)		(209	)		4,778
Income tax (benefit) expense		—		(546	)		—			2,253
Income (loss) from discontinued operations, net of tax	$	3,438	$	480		$	(209	)	$	2,525

Total Discontinued Operations

	For the Thirteen Weeks Ended					For the Thirty Nine Weeks Ended
	(unaudited)					(unaudited)
	November 3,		October 28,			November 3,			October 28,
(in thousands)	2018		2017			2018			2017
Net Sales	$	100,403	$	169,256		$	389,045		$	508,762
Cost of goods sold		80,948		144,670			330,149			426,944
Gross profit		19,455		24,586			58,896			81,818
Depreciation and amortization		616		2,382			4,867			7,559
Selling, general and administrative expenses		15,401		23,734			65,774			70,386
Income (loss) from discontinued operations		3,438		(1,530	)		(11,745	)		3,873
Income tax (benefit) expense		—		(152	)		—			2,497
Income (loss) from discontinued operations, net of tax	$	3,438	$	(1,378	)	$	(11,745	)	$	1,376